N/A
Completed N=4,852
Spiriva Observational Study Measuring Saint George's Respiratory Questionnaire (SGRQ) in Routine Medical Practice in Central & Eastern European Region
Pulmonary Disease, Chronic Obstructive
Source: ClinicalTrials.gov NCT01006135 ↗
Enrolled (actual)
4,852
Serious AEs
0.3%
Results posted
Jul 2012
Primary outcomePrimary: Mean Change of Total Saint George Respiratory Questionnaire (SGRQ) Score at the End of the Observational Period After 6 Months From Baseline — -21.73 Units on a scale
Summary
The objective of this observational study is to collect and evaluate data on Health Related Quality of Life (HRQoL) of Spiriva delivered by HandiHaler, using disease specific SGRQ in the national samples of Central & Central European patients with varying severities of chronic obstructive pulmonary disease (COPD) in the real life setting over the 6 months.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Mean Change of Total Saint George Respiratory Questionnaire (SGRQ) Score at the End of the Observational Period After 6 Months From Baseline |
-21.73 | — |
| SECONDARY Additional Bronchodilator or Inhaled Corticosteroids (ICS) |
1146 | — |
| SECONDARY Compliance of Patients |
3636 | — |
| SECONDARY Patients With Any Adverse Events |
182 | — |
Eligibility Criteria
Inclusion criteria
- 40 years and older male and female ambulatory outpatients.
- Clinical diagnosis of Chronic Obstructive Lung Disease (COPD) (Global Initiative for Chronic Obstructive Lung Disease (GOLD) Guidelines: Forced expiratory Volume in one second (FEV1)/ Forced Vital Capacity (FVC) < 0.7 and FEV1 < 80% predicted).
- Stable patient, without exacerbation for at least one month to the study.
Exclusion criteria
- Uncooperative patients as judged by the physician.
- Patients that have any condition which, according to the participating physician's opinion, might decrease the chance of obtaining satisfactory data to achieve the objectives of the observation study.
- Patients with any conditions excluded as per Country specific package insert.
- Patients currently enrolled in another clinical trial which requires a change in medication for their respiratory problems.
Data sourced from ClinicalTrials.gov (NCT01006135). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.